THE EFFECT OF ANXIETY LEVELS OF TYPE 2 DIABETES MELLITUS PATIENTS ON THEIR TREATMENT ADHERENCE IN THE COVID-19 PANDEMIC PERIOD

International Journal of Health Services Research and Policy Pub Date : 2022-07-29 DOI:10.33457/ijhsrp.1115603

alev yıldırım keskin, Sibel Şentürk, Zeynep Büşra Teke

{"title":"THE EFFECT OF ANXIETY LEVELS OF TYPE 2 DIABETES MELLITUS PATIENTS ON THEIR TREATMENT ADHERENCE IN THE COVID-19 PANDEMIC PERIOD","authors":"alev yıldırım keskin, Sibel Şentürk, Zeynep Büşra Teke","doi":"10.33457/ijhsrp.1115603","DOIUrl":null,"url":null,"abstract":"This study was conducted to investigate the effects of the anxiety levels of Diabetes Mellitus (DM) patients on their treatment adherence in the COVID-19 pandemic period. The sample of this descriptive and cross-sectional study consisted of 313 DM patients who presented to the internal medicine outpatient clinic between 01.01.2021 and 01.02.2021. The data were collected using a Personal Information Form, the Coronavirus Anxiety Scale (CAS), and the Morisky Medication Adherence Scale (MMAS-8). Descriptive statistics, Mann-Whitney U test, Kruskal-Wallis test and Spearman’s correlation test were used to analyze the data. The mean CAS score of the DM patients was 7.89±3.87, while their mean total MMAS-8 score was 4.06±1.56. It was determined that the patients who were using oral antidiabetic medications, those adhering to their medication and diet treatment, and those who were not COVID-19 had higher levels of anxiety. There was a negative significant relationship between the MMAS-8 and CAS scores of the patients (p","PeriodicalId":32502,"journal":{"name":"International Journal of Health Services Research and Policy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Health Services Research and Policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33457/ijhsrp.1115603","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

This study was conducted to investigate the effects of the anxiety levels of Diabetes Mellitus (DM) patients on their treatment adherence in the COVID-19 pandemic period. The sample of this descriptive and cross-sectional study consisted of 313 DM patients who presented to the internal medicine outpatient clinic between 01.01.2021 and 01.02.2021. The data were collected using a Personal Information Form, the Coronavirus Anxiety Scale (CAS), and the Morisky Medication Adherence Scale (MMAS-8). Descriptive statistics, Mann-Whitney U test, Kruskal-Wallis test and Spearman’s correlation test were used to analyze the data. The mean CAS score of the DM patients was 7.89±3.87, while their mean total MMAS-8 score was 4.06±1.56. It was determined that the patients who were using oral antidiabetic medications, those adhering to their medication and diet treatment, and those who were not COVID-19 had higher levels of anxiety. There was a negative significant relationship between the MMAS-8 and CAS scores of the patients (p

查看原文本刊更多论文

新冠肺炎流行期2型糖尿病患者焦虑水平对其治疗依从性的影响

本研究旨在调查新冠肺炎大流行期间糖尿病（DM）患者的焦虑水平对其治疗依从性的影响。这项描述性和横断面研究的样本包括313名DM患者，他们在2021年1月1日至2021年2月1日期间到内科门诊就诊。使用个人信息表、冠状病毒焦虑量表（CAS）和Morisky药物依从性量表（MMAS-8）收集数据。采用描述性统计、Mann-Whitney U检验、Kruskal-Wallis检验和Spearman相关检验对数据进行分析。DM患者的CAS平均得分为7.89±3.87，而他们的MMAS-8总得分平均为4.06±1.56。经确定，使用口服抗糖尿病药物的患者、坚持药物和饮食治疗的患者以及非新冠肺炎患者的焦虑水平较高。MMAS-8与CAS评分呈负相关（p

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Health Services Research and Policy

自引率

0.00%

发文量

审稿时长

5 weeks